Renal protective effects of erythropoietin on ischemic reperfusion injury

Cell Transplantation

Volumn 19, Issue 6-7, 2010, Pages 713-721

  Moriyama, Manabu T ^a   Tanaka, Tatsuro ^a   Morita, Nobuyo ^a   Ishii, Takeo ^a   Chikazawa, Ippei ^a   Suga, Kodai ^a   Miyazawa, Katsuhito ^a   Suzuki, Koji ^a  

^a Kanazawa Medical University   (Japan)

Author keywords

Erythropoietin; Ischemia; Kidney transplantation; Marginal donor; Reperfusion injury

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CREATININE; LIVER ENZYME; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; RECOMBINANT ERYTHROPOIETIN;

ABDOMEN; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD SAMPLING; CONTROLLED STUDY; CREATININE BLOOD LEVEL; GENERAL ANESTHESIA; INFERIOR CAVA VEIN; KIDNEY ARTERY; KIDNEY BLOOD FLOW; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; KIDNEY ISCHEMIA; MALE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENAL PROTECTION; REPERFUSION INJURY; UREA NITROGEN BLOOD LEVEL;

ACUTE-PHASE PROTEINS; ANIMALS; BLOOD UREA NITROGEN; CELL COUNT; CREATININE; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHROPOIETIN, RECOMBINANT; HUMANS; IN SITU NICK-END LABELING; KIDNEY; LIPOCALINS; LIVER; MALE; PROTECTIVE AGENTS; PROTO-ONCOGENE PROTEINS; RATS; REACTIVE OXYGEN SPECIES; REPERFUSION INJURY;

RATTUS;

EID: 77958601743     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368910X508816     Document Type: Article

References (25)

1. Bonsdorff, E.; Jalavisto, E. A humoral mechanism in anatomic erythrocytosis. Acta Physiol. Scand. 16:150-170; 1948.
2. Erbayraktar, S.; Grasso, G.; Sfacteria, A.; Xie, Q. W.; Coleman, T.; Kreilgaard, M.; Torup, L.; Sager, T.; Erbayraktar, Z.; Gokmen, N.; Yilmaz, O.; Ghezzi, P.; Villa, P.; Fratelli, M.; Casagrande, S.; Leist, M.; Helboe, L.; Gerwein, J.; Christensen, S.; Geist, M. A.; Pedersen, L. Ø.; Cerami-Hand, C.; Wuerth, J. P.; Cerami, A.; Brines, M. Asialoerythropietin is a nonerythropoetic cytokine with broad neuroprotective activity in vivo. Proc. Natl. Acad. Sci. USA 100:6741-6746; 2003.
3. Garcia, D. L.; Anderson, S.; Rennke, H. G.; Brenner, B. M. Anemia lessens and its prevention with recombinant human erythropoietin worsens glomerular injury and hypertention in rats with reduced renal mass. Proc. Natl. Acad. Sci. USA 85:6142-6146; 1988.
4. Gouva, C.; Nikolopoulos, P.; Ioannidis, J. P.; Siamopoulos, K. C. Treating anemia early in renal failure patients slows the decline of renal function: A randamized controlled trial. Kidney Int.66:753-760; 2004.
5. Henke, M.; Laszig, R.; Rube, C.; Sch?fer, U.; Haase, K. D.; Schilcher, B.; Mose, S.; Beer, K. T.; Burger, U.; Dougherty, C.; Frommhold, H. Erythropoetin to treat head neck cancer patients with anemia undergoing radiotherapy:randomized, double-blind, placebo-controlled trial. Lancet 362:1255-1260; 2003.
6. Imamura, R.; Okumi, M.; Isaka, Y.; Ichimaru, N.; Moriyama, T.; Imai, E.; Nonomura, N.; Takahara, S.; Okuyama, A. Carbamylated erythropoietin improves angiogenesis and protects the kidneys from ischemia-reperfusion injury. Cell Transplant. 17:135-141; 2008.
7. Jacobson, L. O.; Goldwesser, E.; Plazak, L. F.; Fried, W. Studies on erythropoiesis. IV. Reticulocytes response of hypophysectomized and polycythemic rodents to erythropoietin. Proc. Soc. Exp. Biol. Med. 94:243-249; 1957.
8. Kang, D. H.; Park, E. Y.; Yu, E. S.; Lee, Y. S.; Yoon, K. I. Renoprotective effect of erythropoietin of renal hypoxia with stimulation of angiogenesis in the kidney. Kidney Int. 67:1683; 2005
9. Katavetin, P.; Inagi, R.; Miyata, T.; Shao, J.; Sassa, R.; Adler, S.; Eto, N.; Kato, H.; Fujita, T.; Nangaku, M. Erythropoietin induces heme oxygenase-1 expression and attenuates oxidative stress. Biochem. Biophys. Res. Commun. 359:928-934; 2007.
10. Koene, R. A.; Frenken, L. A. Role of rHurhEPO in treatment of uremic anemia prior to end-stage renal disease. Kidney Int. Suppl. 38:S142-147; 1992.
11. Kuriyama, S.; Tomonari, H.; Yoshida, H.; Hashimoto, T.; Kawaguchi, Y.; Sakai, O. Reversal of anemia by erythropoietin therapy retards the progression of chronic renal failure, especially in nondiabetic patients. Nephron 77:176-185; 1997.
12. Leist, M.; Ghezzi, P.; Grasso, G.; Bianchi, R.; Villa, P.; Fratelli, M.; Savino, C.; Bianchi, M.; Nielsen, J.; Gerwien, J.; Kallunki, P.; Larsen, A. K.; Helboe, L.; Christensen, S.; Pedersen, L. O.; Nielsen, M.; Torup, L.; Sager, T.; Sfacteria, A.; Erbayraktar, S.; Erbayraktar, Z.; Gokmen, N.; Yilmaz, O.; Cerami-Hand, C.; Xie, Q. W.; Coleman, T.; Cerami, A.; Brines, M. Derivatives of erythropoietin that a tissue protective but not erythropoietic. Science 305:239-242; 2004
13. Mishra, J.; Dent, C.; Tarabishi, R.; Mitsnefes, M. M.; Ma, Q.; Kelly, C.; Ruff, S. M.; Zahedi, K.; Shao, M.; Bean, J.; Mori, K.; Barasch, J.; Devarajan, P. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 365:1231-1238; 2005.
14. Moriyama, T.; Imamura, R.; Isaka, Y.; Ichimaru, N.; Imai, E.; Takahara, S.; Okuyama, A. Erythropoietin induces hypoxyia inducible factor-1alpha and protects against ischemia reperfusion injury in rat kidney. J. Am. Soc. Nephrol. 17:511A; 2006.
15. Nemoto, T.; Yokota, N.; Keane, W. F.; Rabb, H. Recombinant erythropoietin rapidly treats anemia in ischemic acute renal failure. Kidney Int. 59:246-251; 2001.
16. Nickolas, T. L.; O'Rourke, M. J.; Yang, J.; Sise, M. E.; Canetta, P. A.; Barasch, N.; Buchen, C.; Khan, F.; Mori, K.; Giglio, J.; Devarajan, P.; Barasch, J. Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury. Ann. Intern. Med. 148:810-819; 2008.
17. Parsa, C. J.; Matsumoto, A.; Kim, J.; Riel, R. U.; Pascal, L. S.; Walton, G. B.; Thompson, R. B.; Petrofski, J. A.; Annex, B. H.; Stamler, J. S.; Koch, W. J. A novel protective effect of erythropoietin in the infarcted heart. J. Clin. Invest. 112:999-1007; 2003.
18. Ramakrishnan, R.; Cheung, W. K.; Farrell, F.; Joffee, L.; Jusko, W. J. Pharmacokinetic and pharmacodynamic modeling of recombinant human erythropoietin after intravenous and subcutaneus dose administraction in cynomolgus monkeys. J. Pharmacol. Exp. Ther. 306:324-331; 2003.
19. Sakanaka, M.; Wen, T. C.; Matsuda, S.; Masuda, S.; Morishita, E.; Nagao, M.; Sasaki, R. In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc. Natl. Acad. Sci. USA 95:4635-4640; 1998.
20. Sasaki, R.; Masuda, S.; Nagao, M. Pleiotropic functions and tissue-specific expression of erythropoietin. News Physiol. Sci. 16:110-113; 2001.
21. Sharples, E. J.; Patel, N.; Brown, P.; Stewart, K.; Mota-Philipe, H.; Sheaff, M.; Kieswich, J.; Allen, D.; Harwood, S.; Raftery, M.; Thiemermann, C.; Yaqoob, M. M. Erythropoietin products the kidney against the injury and dysfunction caused by ischemia-reparfusion. J. Am. Soc. Nephrol. 15:2115-2124; 2004.
22. Slowinski, T.; Schulz, N.; Ruschitzka, F. T.; Quaschning, T.; Bauer, C.; Theuring, F.; Neumayer, H. H.; Gassmann, M.; Hocher, B. Pattern of prepro-endothelin-1 expression revealed by reporter-gene activity in kidneys of erythropoietin-overexpressing mice. Clin. Sci. 103:44S-47S; 2002
23. Suzuki, C.; Isaka, Y.; Shimizu, S.; Tsujimoto, Y. ; Takabatake, Y.; Ito, T.; Takahara, S.; Imai, E. Bcl-2 protects tubular epithelial cells from ischemia reperfusion injury by inhibiting apoptosis. Cell Transplant. 17:223-229; 2008.
24. Tong, E. M.; Nissenson, A. R. Erythropoietin and anemia. Semin. Nephrol. 21:190-203; 2001.
25. Valderrábano, F. Erythropoietin in chronic renal failure. Kidney Int. 50:1373-1391; 1996.